Navigation Links
Alexza to Present at the MDB Bright Lights Conference 2011
Date:5/6/2011

MOUNTAIN VIEW, Calif., May 6, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that company Senior Vice President and Chief Financial Officer, August J. Moretti will present during the MDB Bright Lights Conference 2011.  The Alexza presentation will be on Tuesday, May 10, 2011 at 10:00 a.m. Eastern Time.  The presentation will be webcast live from New York, NY.

To access the presentation via the Web, please go to the Investor Relations tab at www.alexza.com or at http://www.wsw.com/webcast/mdb2/alxa/.  A replay of the webcast will be made available approximately 24 hours after the live presentation and the replay will be archived for 90 days.

Additional information about the MDB Bright Lights Conference 2011 may be found at: http://www.mdb.com/2011-bright-lights-conference.html.

About Alexza Pharmaceuticals, Inc.

Alexza is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being develo
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "Global Neurodegenerative Diseases Market 2015-2019" ... global neurodegenerative diseases market to grow at a ... This report covers the present scenario and ... market for the period 2015-2019. To calculate the ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
(Date:6/3/2015)... Calif. , June 3, 2015  Armetheon, ... molecule drugs for cardiovascular diseases, today announced that ... been appointed Chief Executive Officer, effective immediately. Dr. ... in global, high-growth enterprises, with a successful track ... of human health. With expertise that includes the ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
(Date:6/3/2015)... June 03, 2015 Hexagon Geospatial is ... winner of its 2015 U.S. Education Challenge, which showcases ... a college or university in the U.S. , ... focused on Remote Sensing and Civil Engineering at the ... “Pavement Surface Cracks Detection and Assessment Based on Hyper-spatial ...
(Date:6/3/2015)... 03, 2015 Loma Linda University Health ... with San Gorgonio Memorial Hospital (SGMH). The SGMH board ... May 28. , “Loma Linda University Health has been ... Heinrich, chief executive officer, Loma Linda University Medical Center. ... our services to this community.” , Under the ...
(Date:6/3/2015)... NJ (PRWEB) June 03, 2015 ... across platforms and devices, announced today that it has ... in Collaboration and Content. The company was honored among ... demonstrating excellence in innovation and implementation of customer solutions ... Microsoft Partner of the Year Awards – including the ...
(Date:6/3/2015)... Baltimore, MD (PRWEB) June 03, 2015 ... firm that transforms businesses with technology, announced today that ... Officer. Mr. Dodge joins The Canton Group ... on years of successful customer engagements. , Tim is ... marketing functions for a variety of technology companies. Before ...
(Date:6/3/2015)... June 03, 2015 The National Resident ... that Maria C. Savoia, M.D., Dean of Medical Education at ... will become Chair on July 1. , “It ... the National Resident Matching Program,” said Dr. Savoia. “NRMP’s ... for matching medical students with training programs, and I welcome ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial Announces U.S. Education Challenge Winner at HxGN Live 2015 2Health News:Loma Linda University Health and Adventist Health Enter into Exclusive Affiliation Negotiations with San Gorgonio Memorial Hospital 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 2Health News:AvePoint Wins 2015 Microsoft Partner of the Year Award for Collaboration and Content 3Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4
... The former director of information technology for a ... guilty plea to intruding into her former employer,s computer ... A. Breuer, acting U.S. Attorney Tim Johnson and FBI ... a hearing before U.S. District Judge David Hittner, Danielle ...
... Aranesp, experts say, , , THURSDAY, April 30 (HealthDay News) ... such as Procrit and Aranesp, often used by cancer ... of death and serious adverse events such as blood ... also been associated in prior studies with increased risk ...
... Zealand, April 30 As the world mourns the deaths ... outside of Mexican soil, the World Health Organization has raised ... being confirmed in California, Texas, New York, Maine and Massachusetts, ... New Zealand, people all over the globe are beginning to ...
... As an expectant mother, her first official Mother,s Day doesn,t ... Here are four unique ideas to make this Mother,s Day unforgettable ... rest, this can be a vexing time. She knows it ... off her feet, but she is still very aware that laundry ...
... A new poll by the Pew Research Center,s Forum ... Catholics who have heard about the issue support President ... divisions exist between the most-observant Catholics and those who ... over their assessment of Obama,s job performance.Conducted from April ...
... April 30 Cadence ... company focused on in-licensing, developing and commercializing proprietary product ... announced that it will release its first quarter ended ... on Thursday, May 7, 2009. Cadence management will host ...
Cached Medicine News:Health News:Computer Administrator Pleads Guilty to Hacking Former Employer's Computer System 2Health News:Anemia Drugs May Raise Death Risk in Cancer Patients 2Health News:Anemia Drugs May Raise Death Risk in Cancer Patients 3Health News:Anemia Drugs May Raise Death Risk in Cancer Patients 4Health News:All Natural System Sweeps Swine Flu Out with the Trash 2Health News:Four Unique Gifts for Expectant Moms Includes New Technology That Enhances Pre-Natal Bonding 2Health News:New Poll on Obama, Catholics and the Notre Dame Commencement Finds Deep Divisions Among Catholics 2
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
... leads are implantable bipolar extendable/retractable screw-in ... either the atrium or the ventricle. ... be extended or retracted by turning ... contains an anti-chattering mechanism for steady ...
Used with permanent pacing leads....
... Tupos LA, the only ICD system in ... the first implant for the treatment of ... a lasting improvement of their hemodynamics and ... LA uses biatrial stimulation to effectively suppress ...
Medicine Products: